Search results (6)
« Back to NewsLudwig Oxford retreat 2022 – a recap
15 July 2022
- Barnes
- Boccellato
- Byrne
- Constantinescu
- De Val
- Goding
- Kriaucionis
- Lu
- Mehdipour
- Moura Alves
- Ratcliffe
- Schuster-Böckler
- Shi
- Song
- Van den Eynde
On 13-14th June 2022, the Oxford Branch of the Ludwig Institute for Cancer Research held their annual retreat to discuss key scientific advances within the Branch and beyond.
Ludwig Oxford researcher presents at the Oxford Immunology Symposium
22 April 2021
Dr Pedro Moura Alves described how the aryl hydrocarbon receptor senses bacteria to fine-tune the body’s response to infection
New method for studying AhR interactions
3 March 2021
Dr Pedro Moura Alves has developed a microscale thermophoresis-based approach for rapidly and robustly analysing aryl hydrocarbon receptor interactions.
Targeting the aryl hydrocarbon receptor
20 July 2020
Dr Pedro Moura Alves secures funding to screen for drugs that regulate aryl hydrocarbon receptor (AHR) activity.
Novel strategy for improving tuberculosis treatment
3 January 2020
Pedro Moura Alves demonstrates that drugs used to treat TB interact with the Aryl hydrocarbon receptor to worsen treatment outcomes.
Spying on bacterial communication to fine-tune the body’s defences
20 December 2019
Research published in the journal Science by Ludwig Oxford’s Pedro Moura Alves and Max Planck’s Stefan Kaufmann gives insights into the relationship between bacterial pathogens and the host organism during an infection.